Prestigious Award Honors Groundbreaking Immune System Research

This year's Nobel Prize in medical science has been awarded for revolutionary findings that clarify how the body's defense network attacks harmful infections while protecting the body's own cells.

Three renowned scientists—Japan's Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—received this honor.

The research identified unique "security guards" within the defense system that remove malfunctioning defense cells capable of attacking the body.

The findings are now paving the way for innovative therapies for immune disorders and cancer.

These laureates will divide a monetary award valued at 11m Swedish kronor.

Crucial Findings

"Their research has been decisive for understanding how the immune system functions and the reason we don't all develop serious autoimmune diseases," commented the head of the award panel.

The team's research explain a fundamental question: In what way does the immune system defend us from countless infections while leaving our own tissues intact?

The body's protection system employs white blood cells that scan for indicators of infection, including pathogens and bacteria it has never encountered.

Such cells utilize detectors—known as recognition units—that are produced by chance in a vast number of combinations.

That provides the defense network the ability to combat a broad range of invaders, but the randomness of the process unavoidably creates immune cells that may target the body.

Protectors of the Immune System

Researchers earlier understood that some of these problematic white blood cells were eliminated in the thymus—where white blood cells mature.

The latest Nobel Prize honors the discovery of T-reg cells—known as the body's "peacekeepers"—which patrol the system to neutralize other immune cells that attack the healthy cells.

It is known that this mechanism fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The prize committee added, "The discoveries have established a new field of research and spurred the creation of innovative therapies, for instance for tumors and immune disorders."

In malignancies, T-regs prevent the body from attacking the tumor, so research are focused on lowering their quantity.

In autoimmune diseases, experiments are testing increasing T-reg cells so the organism is not being harmed. A comparable method could also be effective in reducing the risks of organ transplant failure.

Innovative Studies

Prof Sakaguchi, of a Japanese institution, conducted experiments on mice that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that injecting defense cells from other animals could prevent the illness—implying there was a system for blocking immune cells from harming the body.

Dr. Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in mice and humans that resulted in the discovery of a gene vital for how T-regs operate.

"Their pioneering work has revealed how the immune system is controlled by T-reg cells, preventing it from accidentally attacking the healthy cells," commented a prominent biological science specialist.

"The research is a remarkable illustration of how basic physiological research can have far-reaching consequences for human health."